Novo Nordisk — theft of non-public data including personal data

Danish pharmaceutical maker Novo Nordisk disclosed on 11 June that an external party gained unauthorised access to a limited number of internal IT systems and copied non-public data, including personal data (Novo Nordisk; daily 06-13). The company's statement does not itemise the data categories beyond "personal data"; pharma and life-sciences SOCs should nonetheless treat research-data and personal-data repositories as crown-jewel assets, given their value for both espionage and extortion.